Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bacillus Calmette-Guerin Against Covid-19 for Prevention and Amelioration of Severity Trial

NCT04534803 is registered in ClinicalTrials.gov with Harvard Medical School (HMS and HSDM) as lead sponsor.

NCT NCT04534803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04534803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bacillus Calmette-Guerin Against Covid-19 for Prevention and Amelioration of Severity Trial
Lead sponsor
Harvard Medical School (HMS and HSDM)
Phase
Phase 3
Overall status
Withdrawn
Start date
September 30, 2021
Completion date
July 31, 2022
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

covid19